4D Molecular Therapeutics...

NASDAQ: FDMT · Real-Time Price · USD
7.26
0.00 (0.00%)
At close: Aug 18, 2025, 3:59 PM
7.13
-1.79%
After-hours: Aug 18, 2025, 07:54 PM EDT

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics reported an annual revenue of $37K, reflecting a -99.82% growth. For the quarter ending June 30, 2025, 4D Molecular Therapeutics generated $15K in revenue.
Revenue (ttm)
37K
Revenue Growth
-99.82%
Price / Sales Ratio
8120.72
Revenue / Employee
163
Employees
227
Market Cap
339.04M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 37K -99.82%
Dec 31, 2023 20.72M +562.29%
Dec 31, 2022 3.13M -82.65%
Dec 31, 2021 18.04M +32.52%
Dec 31, 2020 13.61M +94.85%
Dec 31, 2019 6.99M -50.56%
Dec 31, 2018 14.13M +144.04%
Dec 31, 2017 5.79M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.